All Research Articles

You searched for  2019-nCoV OR 2019nCoV OR COVID-19 OR SARS-CoV-2 OR ((wuhan AND coronavirus)])
41-60 of 181 ARTICLES
https://doi.org/10.12688/f1000research.25211.1
Systematic Review metrics
Cardiovascular implications of coronavirus disease 2019: a systematic review
[version 1; peer review: 2 not approved]
Peer Reviewers Siddappa N. Byrareddy; Sanjeet Singh Avtaar Singh
PUBLISHED 04 Aug 2020
https://doi.org/10.12688/f1000research.110593.3
Opinion Article metrics
Revised
Surfing Corona waves – instead of breaking them: Rethinking the role of natural immunity in COVID-19 policy
[version 3; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Cassian Minguet; Prof. Michael Marx; Fareed Abdullah
LATEST VERSION PUBLISHED 24 Aug 2023
https://doi.org/10.12688/f1000research.23639.1
Brief Report metrics
The IMPDH inhibitor merimepodib provided in combination with the adenosine analogue remdesivir reduces SARS-CoV-2 replication to undetectable levels in vitro
[version 1; peer review: 2 approved with reservations]
Peer Reviewers Luka Čičin-Šain; Mahmoud Kandeel
  • Funders
  • National Center for Advancing Translational Sciences
  • Trek Therapeutics
  • National Institutes of Health
PUBLISHED 13 May 2020
https://doi.org/10.12688/f1000research.52216.1
Systematic Review metrics
Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis
[version 1; peer review: 2 approved]
Peer Reviewers Ari Fahrial Syam; Mahir Gachabayov
PUBLISHED 19 Apr 2021
https://doi.org/10.12688/f1000research.77421.3
Clinical Practice Article metrics
Revised
The first report on detecting SARS-CoV-2 inside bacteria of  the human gut microbiome: A case series on asymptomatic family members and a child with COVID-19
[version 3; peer review: 2 approved, 1 not approved]
Peer Reviewers Debojyoti Dhar; Aravind Natarajan; Hassan Mohammad Al Emran
LATEST VERSION PUBLISHED 16 Oct 2024
https://doi.org/10.12688/f1000research.73999.3
Research Article metrics
Revised
A computational biology approach for the identification of potential SARS-CoV-2 main protease inhibitors from natural essential oil compounds.
[version 3; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Thi Thanh Binh Nguyen; Rituraj Purohit; Behrooz sadeghi kalani
  • Funder
  • Ministry of Science and Technology, Government of the People’s Republic of Bangladesh
LATEST VERSION PUBLISHED 07 Oct 2024
https://doi.org/10.12688/f1000research.53845.1
Study Protocol metrics
Study protocol for the SeMaCo study: A longitudinal regional cohort study to assess COVID-19 seroprevalence in blood donors
[version 1; peer review: 2 approved with reservations]
Peer Reviewers Thibaud Spinetti; Gannon C.K. Mak
  • Funder
  • Ministry of Science, Economics and Digitization of the Federal State of Saxony-Anhalt
PUBLISHED 29 Sep 2021
https://doi.org/10.12688/f1000research.125780.3
Research Article metrics
Revised
Seroprevalence of exposure to SARS-CoV-2 in domestic dogs and cats and its relationship with COVID-19 cases in the city of Villavicencio, Colombia
[version 3; peer review: 2 approved]
Peer Reviewers Diego A. Forero; Laura C. Bohórquez
  • Funders
  • Pharmacology Laboratory of the School of Animal Sciences of Universidad de los Llanos
  • Secretary of Health of the city of Villavicencio
LATEST VERSION PUBLISHED 10 Aug 2023
https://doi.org/10.12688/f1000research.23829.2
Research Article metrics
Revised
Computational screening for potential drug candidates against the SARS-CoV-2 main protease
[version 2; peer review: 2 approved]
Peer Reviewers Murtaza Tambuwala; Alaa A A Aljabali
  • Funder
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
LATEST VERSION PUBLISHED 21 Dec 2020
https://doi.org/10.12688/f1000research.72896.4
Research Article metrics
Revised
Prediction of the effects of the top 10 synonymous mutations from 26645 SARS-CoV-2 genomes of early pandemic phase
[version 4; peer review: 1 approved, 3 approved with reservations, 2 not approved]
Peer Reviewers Takahiko Koyama; Leyi Wang; Chandran Nithin; Roland Huber; Diego Forni; Tamar Schlick
  • Funder
  • Multimedia University, Malaysia IRFund 2.0
LATEST VERSION PUBLISHED 18 Sep 2024
https://doi.org/10.12688/f1000research.24074.1
Research Article metrics
Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain
[version 1; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Candan Hizel; Shailendra Dwivedi; Amjad Ali
  • Funders
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
PUBLISHED 09 Jun 2020
https://doi.org/10.12688/f1000research.36371.1
Research Article metrics
Reverse vaccinology approach towards the in-silico multiepitope vaccine development against SARS-CoV-2
[version 1; peer review: 2 approved]
Peer Reviewers Sivaraman Natarajan; Tirumala Bharani K. Settypalli
PUBLISHED 23 Jan 2021
https://doi.org/10.12688/f1000research.109236.2
Research Article metrics
Revised
Evidence of SARS-CoV-2 bacteriophage potential in human gut microbiota
[version 2; peer review: 1 approved, 2 approved with reservations]
Peer Reviewers M. Anwar Hossain and Md. Shaminur Rahman; Didier Raoult; Zhonghan Sun
  • Funder
  • Joint Research Centre
LATEST VERSION PUBLISHED 23 Apr 2025
https://doi.org/10.12688/f1000research.53652.1
Case Report metrics
Case Report: Reinfection of COVID-19, with second infection less severe
[version 1; peer review: 1 approved]
Peer Reviewers Aida B. Allawe
PUBLISHED 15 Jul 2021
https://doi.org/10.12688/f1000research.72904.2
Research Article metrics
Revised
Prediction of the effects of the top 10 nonsynonymous variants from 30229 SARS-CoV-2 strains on their proteins
[version 2; peer review: 2 approved]
Peer Reviewers Ujwal Ranjit Bagal and Vishal Nayak; In-Hee Lee
  • Funder
  • Multimedia University
LATEST VERSION PUBLISHED 18 May 2022
https://doi.org/10.12688/f1000research.23805.2
Brief Report metrics
Revised
Analyses of spike protein from first deposited sequences of SARS-CoV2 from West Bengal, India
[version 2; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Pawan Kumar Maurya; Jalaj Gupta; Nicolas Cuburu
LATEST VERSION PUBLISHED 27 Sep 2023
https://doi.org/10.12688/f1000research.23543.1
Review metrics
COVID-19 in pregnancy: What do we really know?
[version 1; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Alfonso J. Rodriguez-Morales; Caterina Montagnoli
PUBLISHED 14 May 2020
https://doi.org/10.12688/f1000research.53966.2
Review metrics
Revised
Covid-19-induced pulmonary hypertension in children, and the use of phosphodiesterase-5 inhibitors
[version 2; peer review: 1 approved, 2 approved with reservations]
Peer Reviewers Sukman Tulus Putra; Ajay Kumar Mishra; Mahrus A Rahman and Prima Nastiti
LATEST VERSION PUBLISHED 12 Sep 2022
https://doi.org/10.12688/f1000research.84355.4
Case Report metrics
Revised
Case Report: Glans penile necrosis in a patient with SARS-CoV-2 and leprosy infection
[version 4; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Harrina Erlianti Rahardjo; Serena Bianchi and Diana Torge; Amílcar Sabino Damazo
LATEST VERSION PUBLISHED 05 Feb 2024
https://doi.org/10.12688/f1000research.24164.1
Software Tool Article metrics
Online dashboard and data analysis approach for assessing COVID-19 case and death data
[version 1; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Maria Florencia Pollo-Cattaneo; Olmer Garcia-Bedoya; Hüseyin Bicen
PUBLISHED 08 Jun 2020
41-60 of 181 ARTICLES
Articles
We publish a wide range of article types in science, engineering, medicine, social sciences and humanities, with no editorial biases.
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.